Tvardi Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Sugar Land, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Tvardi Therapeutics, Inc. has filed 801 SEC EDGAR filings since 06 Dec 2005

SEC filing history

Showing 601-625 of 796 matching filings.

Per page
25
Current page
25
SC 13G/A File 005-87880

CARA THERAPEUTICS

Filing date
10 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jul 2017
Reporting date
29 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
22 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
11 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36279

DEFA14A

Filing date
10 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36279

DEF 14A

Filing date
10 May 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87880

SC 13G/A filing

Filing date
09 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
04 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
03 Apr 2017
Reporting date
30 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-216657

FINAL PROSPECTUS SUPPLEMENT

Filing date
31 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-216657

PRELIMINARY PROSPECTUS SUPPLEMENT

Filing date
29 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
28 Mar 2017
Reporting date
28 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-216657

EFFECT filing

Filing date
24 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
22 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-216657

S-3

Filing date
13 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .